FDA
approval
· 2022-06-27
FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (Alembic Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for olmesartan medoxomil submitted by Alembic Pharmaceuticals Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)